Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Endothelial to mesenchymal Notch signaling regulates skeletal repair
Sanja Novak, Hitoshi Tanigawa, Vijender Singh, Sierra H. Root, Tannin A. Schmidt, Kurt D. Hankenson, Ivo Kalajzic
Sanja Novak, Hitoshi Tanigawa, Vijender Singh, Sierra H. Root, Tannin A. Schmidt, Kurt D. Hankenson, Ivo Kalajzic
View: Text | PDF
Research Article Bone biology

Endothelial to mesenchymal Notch signaling regulates skeletal repair

  • Text
  • PDF
Abstract

We present a transcriptomic analysis that provides a better understanding of regulatory mechanisms within the healthy and injured periosteum. The focus of this work is on characterizing early events controlling bone healing during formation of periosteal callus on day 3 after fracture. Building on our previous findings showing that induced Notch1 signaling in osteoprogenitors leads to better healing, we compared samples in which the Notch 1 intracellular domain is overexpressed by periosteal stem/progenitor cells, with control intact and fractured periosteum. Molecular mechanisms and changes in skeletal stem/progenitor cells (SSPCs) and other cell populations within the callus, including hematopoietic lineages, were determined. Notably, Notch ligands were differentially expressed in endothelial and mesenchymal populations, with Dll4 restricted to endothelial cells, whereas Jag1 was expressed by mesenchymal populations. Targeted deletion of Dll4 in endothelial cells using Cdh5CreER resulted in negative effects on early fracture healing, while deletion in SSPCs using α-smooth muscle actin–CreER did not impact bone healing. Translating these observations into a clinically relevant model of bone healing revealed the beneficial effects of delivering Notch ligands alongside the osteogenic inducer, BMP2. These findings provide insights into the regulatory mechanisms within the healthy and injured periosteum, paving the way for novel translational approaches to bone healing.

Authors

Sanja Novak, Hitoshi Tanigawa, Vijender Singh, Sierra H. Root, Tannin A. Schmidt, Kurt D. Hankenson, Ivo Kalajzic

×

Figure 4

Notch signaling in fracture healing.

Options: View larger image (or click on image) Download as PowerPoint
Notch signaling in fracture healing.
(A) Feature plot of Dll4 expression...
(A) Feature plot of Dll4 expression within periosteal cells. (B) Experimental design of recombination efficiency evaluation by determining mRNA expression of Dll4 and Notch downstream signaling genes (Hes1 and Hey1) in male and female mice. To induce recombination, tamoxifen (Tx) was injected at 0, 2, and 4 dpf, and gene expression was evaluated at 7 dpf. Dll4 was successfully deleted in male mice, with decreased expression of Hes1 and Hey1 in the Cre+ callus (C) and lungs (D). Males: Cre– n = 6, Cre+ n = 6; females: Cre– n = 5, Cre+ n = 5. (E) Proportion of thymocyte subpopulations in the thymus, where deletion of Dll4 in ECs on day 5 after the first tamoxifen injection induced a small decrease in CD4+ cells and an increase in CD8+ cells, with representative dot plots. (F) Flow cytometry analysis showing dot plots of CD31+ cells within the callus at 5 dpf expressing DLL4. (G) Proportion of callus cells expressing Sca1, CD90, PDGFRα, and CD51 at 5 dpf, with representative overlaid histograms of Sca1 and CD90 cell expression (unstained control, Cre– and Cre+ sample). In E–G, Cre– n = 3, Cre+ n = 4. Unpaired, 2-tailed Student’s t test. *P < 0.05.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts